Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms
Hypha Labs (OTCQB:FUNI), creator of MicroPearls™ and functional mushroom products, welcomes potential regulatory changes for functional mushrooms across multiple states. The company sees parallels with cannabis legalization, noting growing acceptance across red, blue, and purple states, particularly regarding mushroom ingredients' potential benefits for PTSD treatment among veterans.
CEO Stone Douglass emphasized that functional mushrooms are gaining popularity and positioned for significant growth as awareness, research, and acceptance converge. The company highlights its innovative countertop device, comparable in size to a blender, enabling home-based mushroom cultivation for personal use.
Hypha Labs (OTCQB:FUNI), creatore di MicroPearls™ e prodotti a base di funghi funzionali, accoglie con favore i potenziali cambiamenti normativi per i funghi funzionali in diversi stati. L'azienda vede paralleli con la legalizzazione della cannabis, notando una crescente accettazione attraverso stati rossi, blu e viola, in particolare riguardo ai potenziali benefici degli ingredienti a base di funghi per il trattamento del PTSD tra i veterani.
Il CEO Stone Douglass ha sottolineato che i funghi funzionali stanno guadagnando popolarità e sono posizionati per una crescita significativa man mano che consapevolezza, ricerca e accettazione si convergono. L'azienda mette in evidenza il suo innovativo dispositivo da cucina, comparabile in dimensioni a un frullatore, che consente la coltivazione domestica di funghi per uso personale.
Hypha Labs (OTCQB:FUNI), creador de MicroPearls™ y productos de hongos funcionales, da la bienvenida a posibles cambios regulatorios para los hongos funcionales en múltiples estados. La compañía ve paralelismos con la legalización del cannabis, señalando una creciente aceptación en estados rojos, azules y morados, especialmente con respecto a los potenciales beneficios de los ingredientes de hongos para el tratamiento del PTSD entre los veteranos.
El CEO Stone Douglass enfatizó que los hongos funcionales están ganando popularidad y están posicionados para un crecimiento significativo a medida que la concienciación, la investigación y la aceptación convergen. La compañía destaca su innovador dispositivo de mostrador, comparable en tamaño a una licuadora, que permite el cultivo doméstico de hongos para uso personal.
하이파랩스 (OTCQB:FUNI), 마이크로펄스™와 기능성 버섯 제품의 제작자는 여러 주에서의 기능성 버섯에 대한 잠재적인 규제 변화에 환영의 뜻을 전했습니다. 이 회사는 의료용 대마초의 합법화와 유사한 점이 있으며, 빨강, 파랑, 보라색 주들에서의 수용이 증가하고 있음을 언급하며, 특히 PTSD 치료를 위한 버섯 성분의 잠재적 이점에 대해 강조했습니다.
CEO 스톤 더글라스는 기능성 버섯이 인기를 얻고 있으며, 인식, 연구 및 수용이 융합됨에 따라 크게 성장할 것으로 예상된다고 강조했습니다. 이 회사는 블렌더 크기와 유사한 혁신적인 조리대 장비를 강조하며, 개인 용도를 위한 홈 기반 버섯 재배를 가능하게 합니다.
Hypha Labs (OTCQB:FUNI), créateur de MicroPearls™ et de produits à base de champignons fonctionnels, se félicite des éventuels changements réglementaires concernant les champignons fonctionnels dans plusieurs États. L'entreprise établit des parallèles avec la légalisation du cannabis, notant une acceptation croissante dans les États rouges, bleus et violets, en particulier concernant les avantages potentiels des ingrédients à base de champignons pour le traitement du PTSD chez les vétérans.
Le PDG Stone Douglass a souligné que les champignons fonctionnels gagnent en popularité et sont positionnés pour une croissance significative à mesure que la sensibilisation, la recherche et l'acceptation convergent. L'entreprise met en avant son dispositif innovant de comptoir, comparable en taille à un mixeur, permettant la culture de champignons à domicile pour un usage personnel.
Hypha Labs (OTCQB:FUNI), der Schöpfer von MicroPearls™ und funktionalen Pilzprodukten, begrüßt potenzielle regulatorische Änderungen für funktionale Pilze in mehreren Bundesstaaten. Das Unternehmen sieht Parallelen zur Legalisierung von Cannabis und stellt fest, dass die Akzeptanz in roten, blauen und lila Bundesstaaten zunimmt, insbesondere in Bezug auf die potenziellen Vorteile von Pilzzutaten zur Behandlung von PTSD bei Veteranen.
CEO Stone Douglass betonte, dass funktionale Pilze an Popularität gewinnen und gut positioniert sind, um signifikantes Wachstum zu erzielen, da Bewusstsein, Forschung und Akzeptanz zusammenkommen. Das Unternehmen hebt sein innovatives Küchengerät hervor, das in der Größe einem Mixer ähnlich ist und den Anbau von Pilzen zu Hause für den persönlichen Gebrauch ermöglicht.
- Potential market expansion through regulatory changes across multiple states
- Strategic positioning with home cultivation device ahead of potential regulatory changes
- None.
Legislative Changes Usher Acceptance, Broaden Market Opportunity for Early Adopters
LAS VEGAS, NV / ACCESS Newswire / January 27, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, applauds the widespread push for regulatory changes for functional mushrooms across numerous states in the country.
A recent article capsulizes the wide array of legislative initiatives across the country looking to advance functional mushroom ingredients for the benefit of those suffering from conditions such as Post-Traumatic Stress Disorder (PTSD) where mushroom ingredients have shown indications of efficacy, especially for the vast population of American veterans suffering from the condition.
From the article, "As cannabis reform spreads across the country, (some mushrooms) are seen as the next frontier. Several communities have decriminalized (certain) compounds as studies continue to show their potential benefits."
"We are most pleased to see these potential changes ahead for functional mushrooms," stated Stone Douglass, CEO, Hypha Labs. "It is in our estimation long overdue and mirrors in many ways the sea change of events that saw to the legalization of cannabis and cannabis products, creating in many ways a revolution of self-care for millions of Americans who wanted a natural way to feel better."
"The popularity of functional mushrooms of all varieties is well-established, and in our opinion, poised to explode as awareness, research, and acceptance converge to allow for individuals and perhaps even Big Pharma to help individuals utilize the all-natural magic of the mushroom in significant ways. It is worth noting that these proposed changes are occurring in Red, Blue and Purple states."
"And it is not lost on us that we believe we have democratized the process of producing mushrooms of all varieties by creating an amazing device that allows for a user to produce a harvest of mushroom ingredients in a sleek appliance no bigger than a blender that sits on a countertop in the privacy of their home.
"As these legislative changes simultaneously open self-care and new markets we are well-positioned to meet the need with our revolutionary device," added Douglass.
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity MediaInc.
(888) 216-3595
team@integritymedia.com
Contact Information
Kurt Divich
President, Integrity Media Inc.
team@integritymedia.com
(888) 216-3595
SOURCE: Hypha Labs, Inc.
View the original press release on ACCESS Newswire
FAQ
What regulatory changes is Hypha Labs (FUNI) responding to in January 2025?
How is Hypha Labs (FUNI) positioned to benefit from mushroom regulation changes?
What market opportunity does FUNI see in the functional mushroom sector?
How does Hypha Labs' MicroPearls technology align with changing mushroom regulations?
